* Pediatrix Medical Group Inc MD.N MD is expected
to show a
rise in quarterly revenue when it reports results on February
17.
* The Sunrise Florida-based company is expected to report
a
0.7% increase in revenue to $501.986 million from $498.53
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Pediatrix Medical
Group
Inc is for earnings of 48 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 6
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Pediatrix
Medical
Group Inc is $17, above its last closing price of $14.81.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.54 0.55 0.40 Missed -26.9
Jun. 30 2022 0.48 0.48 0.47 Missed -1.1
Mar. 31 2022 0.27 0.27 0.33 Beat 21.1
Dec. 31 2021 0.44 0.44 0.52 Beat 19.2
Sep. 0.42 0.42 0.46 Beat 10.6
30 2021
Jun. 30 2021 0.32 0.32 0.41 Beat 26.4
Mar. 31 2021 0.11 0.13 0.24 Beat 80.9
Dec. 31 2020 0.36 0.36 0.25 Missed -29.8
This summary was machine generated February 15 at 13:32 GMT.
All figures in US dollars unless otherwise stated